ezetimibe has been researched along with Liver Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morinaga, Y; Nakazato, M; Shiiya, T; Tamaki, N; Ueno, H | 1 |
Beuers, U; Bosma, PJ; de Knegt, RJ; de Waart, DR; Duijst, S; Finel, M; Montenegro-Miranda, PS; Sneitz, N; Ten Bloemendaal, L | 1 |
Cesena, FH; Luz, PL; Xavier, HT | 1 |
Becx, MC; Kuypers, KC; Seldenrijk, CA; Stolk, MF | 1 |
4 other study(ies) available for ezetimibe and Liver Diseases
Article | Year |
---|---|
Ezetimibe ameliorates atherosclerotic and inflammatory markers, atherogenic lipid profiles, insulin sensitivity, and liver dysfunction in Japanese patients with hypercholesterolemia.
Topics: Administration, Oral; Anticholesteremic Agents; Asian People; Atherosclerosis; Azetidines; Biomarkers; Case-Control Studies; Ezetimibe; Female; Humans; Hypercholesterolemia; Inflammation; Insulin Resistance; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Liver Diseases; Male; Matrix Metalloproteinase 9; Middle Aged; Prognosis; Prospective Studies; Vascular Cell Adhesion Molecule-1 | 2012 |
Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemia.
Topics: Animals; Azetidines; Bilirubin; Biomarkers; Crigler-Najjar Syndrome; Disease Models, Animal; Ezetimibe; Female; Genetic Therapy; Genetic Vectors; Glucuronosyltransferase; Humans; Liver; Liver Diseases; Male; Random Allocation; Rats; Rats, Gunn | 2012 |
[Hypolipidemic therapy in special situations: hypothyroidism and liver disease].
Topics: Age Factors; Azetidines; Clofibrate; Drug Interactions; Dyslipidemias; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothyroidism; Liver Diseases; Male; Sex Factors; Thyrotropin | 2005 |
Severe hepatic side effects of ezetimibe.
Topics: Anticholesteremic Agents; Atorvastatin; Azetidines; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Ezetimibe; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Liver Diseases; Male; Middle Aged; Pyrroles; Transaminases | 2006 |